Skip to main content
Caplight Logo









Nuapoch, Inc.

Nuapoch, Inc.

Private
Oakland, CaliforniaHealthcare & Life Scienceshttps://www.malecontraceptive.org/

Last Round

Grant

Jan 30, 2026

Total Funding Raised

$4.45M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Nuapoch, Inc. is a biotechnology company that develops non-hormonal, reversible male contraceptive methods by targeting sperm maturation factors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

male contraceptivenon-hormonal contraceptivemale birth controlbiotechnologydrug discoveryreproductive healthpharmaceutical R&Dreversible contraceptivesperm maturationepididymal proteinbirth control pill

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nuapoch, Inc. Comparables

Compare Nuapoch, Inc. with similar companies based on industry and business-model similarity.

Nuapoch, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sacyl Pharmaceuticals
89%
YourChoice Therapeutics
87%
Eppin Pharma Inc.
85%

Nuapoch, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJan 30, 2026
Series AMar 24, 2025
SeedJan 18, 2024
SeedJun 5, 2023

Nuapoch, Inc. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 30, 2026

    $400K grant from Male Contraceptive Initiative.

  • Mar 24, 2025

    $20M round completed.

Nuapoch, Inc. Filings

Explore SEC and related filing metadata, where available.

Nuapoch, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Nuapoch, Inc.'s valuation, stock price, and market status.

Is Nuapoch, Inc. a public or private company?

Nuapoch, Inc. is a private company.

What is the current stock price of Nuapoch, Inc.?

Nuapoch, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Nuapoch, Inc. worth (valuation)?

Valuation information for Nuapoch, Inc. is not publicly available.

Can I buy Nuapoch, Inc. stock?

Nuapoch, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Nuapoch, Inc.'s last funding round?

Nuapoch, Inc.'s most recent funding round was Grant on January 30, 2026.

Who are the main investors in Nuapoch, Inc.?

Key investors in Nuapoch, Inc. include TheFamily.

Will Nuapoch, Inc. IPO soon?

No public IPO plans have been announced for Nuapoch, Inc..

How can I track Nuapoch, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nuapoch, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersOakland, California
Year Founded2024
Last FundingJan 30, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?